GENEVA / KINSHASA — The World Health Organization (WHO) has sounded an urgent alarm over a rapidly evolving outbreak of Bundibugyo virus disease (BVD)—a rare, severe, and currently untreatable strain of Ebola—that is expanding across the Democratic Republic of the Congo (DRC) and spilling over borders into Uganda.
In a technical brief released May 29, 2026, the WHO classified the outbreak as a "very high" risk at the national level for the DRC and "high" at the regional level. The situation has intensified fiercely over the last week, marked by a surge of 49 newly confirmed cases and eight deaths in a matter of days.
 |
| The Bundibugyo virus particle, a member of the Orthoebolavirus species that lacks an approved vaccine.Source: Science Sparks |
Adding an international dimension to the crisis, a medical doctor from the United States contracted the virus while treating patients in the DRC. The physician tested positive on May 17 and was medically evacuated via a high-containment flight to Germany, where they are currently receiving specialized care.
The Outbreak by the Numbers
The scale of the outbreak has caught regional health tracking systems in a severe bottleneck. The combined data from both nations paints a sobering picture of the crisis:
Suspected Cases: 906 suspected cases have been flagged, resulting in 223 suspected deaths (all within the DRC).
Confirmed Cases: 134 cases have been officially verified via laboratory testing—125 in the DRC and 9 in Uganda.
Confirmed Fatalities: 18 people have died from laboratory-confirmed infections (17 in the DRC, 1 in Uganda).
The Death Rate: The current Case Fatality Rate (CFR) among confirmed patients stands at 14%. However, historical outbreaks of this specific strain have seen mortality rates climb between 30% and 50%.
Epicenter Under Siege: Security and Resistance in the DRC
The overwhelming majority of transmission is tearing through the eastern provinces of the DRC, with Ituri Province serving as the epicenter, holding 88% (110 cases) of all confirmed infections. Hotspots have flared up heavily within the health zones of Bunia (37 cases), Rwampara (33 cases), and Mongbwalu (20 cases).
Medical emergency teams on the ground are running into severe operational roadblocks. The WHO noted that three recent security incidents targeting healthcare facilities in Mongbwalu and Rwampara have severely disrupted containment measures. Compounding the violence is deep-seated community resistance, which is actively hindering contact tracers who are struggling to monitor 2,635 high-risk contacts.
Furthermore, laboratory infrastructure is buckling under the weight of the surge. Over 100 collected samples are currently stuck in a transit backlog waiting to be sent to the capital city of Kinshasa for molecular analysis, meaning the current official case counts are likely a severe underestimation.
Transit Hubs on Guard: Uganda Cluster Climbs
Across the border, Uganda is racing to prevent an urban explosion after confirming nine cases across its capital city, Kampala (8 cases), and nearby Wakiso (1 case).
Epidemiologists have traced the Ugandan cluster back to porous borders and healthcare exposures. The confirmed patients include:
A Ugandan driver who transported the initial cross-border patient.
A Congolese health worker linked directly to the index case.
A Congolese woman who crossed the border specifically to seek medical attention.
Two Ugandan hospital workers who were infected while managing these patients.
Ugandan authorities have rapidly placed 436 close household and hospital contacts under strict daily medical surveillance.
What is Bundibugyo Virus Disease?
Bundibugyo virus disease is a highly lethal form of hemorrhagic fever caused by the Bundibugyo virus, a distinct species within the Orthoebolavirus genus.
The Transmission: It is a zoonotic virus naturally carried by fruit bats. Humans typically contract it through contact with infected wildlife, which quickly triggers human-to-human spread through direct contact with blood, bodily fluids, or contaminated surfaces.
The Mimicry Trap: The incubation period lasts between 2 to 21 days. Crucially, early symptoms—such as fever, profound fatigue, muscle aches, and a sore throat—are completely non-specific. Because it perfectly mimics common local endemic illnesses like malaria, patients are rarely isolated early, leading to widespread transmission before doctors realize they are dealing with Ebola.
No Available Cure: While the international community successfully developed vaccines (like Ervebo) for the common Zaire strain of Ebola, there are zero approved vaccines or targeted antiviral treatments for the Bundibugyo strain. Containment relies entirely on rapid isolation, rigorous tracking, and supportive clinical care.
Global Response Strategy
Reflecting the gravity of the emergency, WHO Director-General Dr. Tedros Adhanom Ghebreyesus traveled directly to the DRC on May 28 to anchor the multi-agency response, deploying rapid response teams and emergency medical supplies.
Despite the cross-border spread, the WHO issued a firm directive advising against any international travel or trade restrictions targeting the DRC or Uganda. The agency emphasized that closing borders disrupts vital economic supply chains and drives transmission underground, whereas enhanced cross-border surveillance, strict airport screening, and deep community engagement remain the most effective tools to halt the virus.
